Skip to main content

HMG-CoA-reductase-inhibitors

  • Reference work entry
Encyclopedic Reference of Molecular Pharmacology
  • 602 Accesses

Erik Berg Schmidt, Mogens Lytken Larsen

Department of Preventive Cardiology, Aalborg Hospital, Denmark; Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark

ebs@dadlnet.dk, mogenslytkenlarsen@dadlnet.dk

Synonyms

Statins

Definition

A class of important pharmacological compounds that are the most effective drugs for lowering plasma levels of total cholesterol and in particular low-density-lipoprotein (LDL)-cholesterol.

Mechanism of Action

HMG-CoA-reductase-inhibitors (statins) inhibit the enzyme HMG-CoA-reductase that catalyzes the conversion of acetyl coenzyme A to mevalonate, which through several further biochemical steps is metabolized to cholesterol (Fig. 1). HMG-CoA-reductase is the rate-limiting enzyme for the endogenous formation of cholesterol in the human body, which takes place primarily in the liver. The reduced production of cholesterol leads to an increased formation (upregulation) of so-called LDL-receptorson the surface of hepatic cells that remove...

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 270.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Law MR, Wald NJ, Thompson SG (1994) By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease. Br Med J 308:367–373

    CAS  Google Scholar 

  2. Wood D, de Backer G, Faergeman O, Graham I, Mancia G, Pyorala K (1998) Prevention of coronary heart disease in clinical practice. Eur Heart J 19:1434–1503

    Article  Google Scholar 

  3. Knopp RH (1999) Drug treatment of lipid disorders. N Engl J Med 341:498–511

    Article  PubMed  CAS  Google Scholar 

  4. Vaughan CJ, Gotto AM, Basson CT (2000) The evolving role of statins in the management of atherosclerosis. J Am Coll Cardiol 35:1–10

    Article  PubMed  CAS  Google Scholar 

  5. Illingworth DR (2000) The management of hypercholesterolemia. Med Clin North Am 84:23–42

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer-Verlag

About this entry

Cite this entry

(2004). HMG-CoA-reductase-inhibitors. In: Encyclopedic Reference of Molecular Pharmacology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-29832-0_772

Download citation

  • DOI: https://doi.org/10.1007/3-540-29832-0_772

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-42843-5

  • Online ISBN: 978-3-540-29832-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics